Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1983 1
1984 3
1985 2
1986 1
1987 3
1989 6
1990 5
1991 4
1992 1
1993 1
1994 3
1995 5
1996 3
1997 3
1998 4
1999 8
2000 7
2001 6
2002 4
2003 4
2004 7
2005 10
2006 3
2007 6
2008 9
2009 4
2010 5
2011 2
2012 7
2013 7
2014 2
2015 1
2017 2
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Systematic localization of common disease-associated variation in regulatory DNA.
Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J, Shafer A, Neri F, Lee K, Kutyavin T, Stehling-Sun S, Johnson AK, Canfield TK, Giste E, Diegel M, Bates D, Hansen RS, Neph S, Sabo PJ, Heimfeld S, Raubitschek A, Ziegler S, Cotsapas C, Sotoodehnia N, Glass I, Sunyaev SR, Kaul R, Stamatoyannopoulos JA. Maurano MT, et al. Among authors: raubitschek a. Science. 2012 Sep 7;337(6099):1190-5. doi: 10.1126/science.1222794. Epub 2012 Sep 5. Science. 2012. PMID: 22955828 Free PMC article.
T-cell genetic modification for re-directed tumor recognition.
Cooper LJ, Kalos M, DiGiusto D, Brown C, Forman SJ, Raubitschek A, Jensen MC. Cooper LJ, et al. Among authors: raubitschek a. Cancer Chemother Biol Response Modif. 2005;22:293-324. doi: 10.1016/s0921-4410(04)22014-2. Cancer Chemother Biol Response Modif. 2005. PMID: 16110618 Review. No abstract available.
Imaging glioma extent with 131I-TM-601.
Hockaday DC, Shen S, Fiveash J, Raubitschek A, Colcher D, Liu A, Alvarez V, Mamelak AN. Hockaday DC, et al. Among authors: raubitschek a. J Nucl Med. 2005 Apr;46(4):580-6. J Nucl Med. 2005. PMID: 15809479 Free article. Clinical Trial.
Human T lymphocyte genetic modification with naked DNA.
Jensen MC, Clarke P, Tan G, Wright C, Chung-Chang W, Clark TN, Zhang F, Slovak ML, Wu AM, Forman SJ, Raubitschek A. Jensen MC, et al. Among authors: raubitschek a. Mol Ther. 2000 Jan;1(1):49-55. doi: 10.1006/mthe.1999.0012. Mol Ther. 2000. PMID: 10933911 Free article.
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE, Raubitschek AA. Wong JY, et al. Among authors: raubitschek aa. J Nucl Med. 1997 Dec;38(12):1951-9. J Nucl Med. 1997. PMID: 9430476 Free article. Clinical Trial.
Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.
Mortimer JE, Bading JR, Park JM, Frankel PH, Carroll MI, Tran TT, Poku EK, Rockne RC, Raubitschek AA, Shively JE, Colcher DM. Mortimer JE, et al. Among authors: raubitschek aa. J Nucl Med. 2018 Jan;59(1):38-43. doi: 10.2967/jnumed.117.193888. Epub 2017 Jun 21. J Nucl Med. 2018. PMID: 28637802 Free PMC article.
134 results